HMRI National and International Lectures

The doctors of HMRI present their research findings, their expertise on retinal diseases, surgical techniques, etc. at numerous national and international ophthalmological meetings and conferences.  Their recent presentations are listed below.

March 23, 2019. Controversies and Debates: 1st Line of Treatment for PCV. Gregg T. Kokame, MD, MMM Retina World Congress. Fort Lauderdale, Florida.

March 7, 2019. Mystery Case. Asia-Pacific Academy of Ophthalmology. Gregg T. Kokame, MD, MMM. Bangkok, Thailand.

March 4, 2019. PCV in Asia and in the World. Gregg T. Kokame, MD, MMM. Department of Ophthalmology, Retina Division, Chiang-Mai University, Chiang-Mai, Thailand.

December 16, 2018. New Findings on Anti-VEGF Resistance in PCV. Gregg T. Kokame, MD, MMM. 12th Annual APVRS. Seoul, South Korea.

December 15, 2018.  A new surgical therapy for exudative AMD and PCV with episcleral brachytherapy. Gregg T. Kokame, MD, MMM. 12th Annual APVRS. Seoul, South Korea.

December 13, 2018. A Global Perspective: epidemiology, diagnostic challenges and treatment patterns in PCV: PCV in the USA. Gregg T. Kokame, MD, MMM. International Polypoidal Choroidal Vasculopathy Forum. Seoul, South Korea.

October 30, 2018. Diagnosis and Treatment of Polypoidal Choroidal Vasculopathy. Subspecialty Course. Gregg T. Kokame, MD, MMM. American Academy of Ophthalmology. Annual Meeting. Chicago, IL

September 15, 2018. Clinical Characteristics of Polypoidal Choroidal Vasculopathy in Caucasian Patients and Prevalence of Anti-Vascular Endothelial Growth Factor Resistance. Gregg T. Kokame, MD, MMM. Retina Society. Annual Meeting. San Francisco, CA

September 14, 2018. The Presence of Collateral Vessels is a Useful Prognostic Sign in Patients with Retinal Vein Occlusions . James C. Lai, MD. Retina Society. Annual Meeting. San Francisco, CA.

July 22, 2018. The Long-Term Stability of Sutured Scleral-Fixated Posterior Chamber Intraocular Lenses. American Society of Retina Specialists. Gregg T. Kokame, MD, MMM. Annual Meeting. Vancouver, Canada.

June 21, 2018. Update on Diagnosis and Treatment of the PCV Variant of Wet AMD. Gregg T. Kokame, MD, MMM. OIC/WAVE 2018. Annual Meeting. Vail, CO

May 20, 2018. Determining the Prevalence of PCV in Anti-VEGF Resistant Eyes; The Sensitivity and Specificity of Detecting PCV with En-Face OCT and OCTA. Gregg T. Kokame, MD, MMM. American Ophthalmological Society. Dana Point, California.

February 21, 2018. ICG-Guided PDT for PCV. Gregg T. Kokame, MD, MMM. Doheny/Stein Case Conference. Los Angeles, California.

December 8, 2017. Long Term Results of Argus 2 Retinal Prosthesis: The Long Road to Bioelectronics in Ophthalmology. Gregg T. Kokame, MD, MMM. 11th Asia-Pacific Vitreoretina Society Congress. Kuala Lumpur, Malaysia.

December 9, 2017. Management of Late Onset Buckle Intrusion Due to Hydrogel Buckle Swelling. Gregg T. Kokame, MD, MMM. 11th Asia-Pacific Vitreoretina Society Congress. Kuala Lumpur, Malaysia.

November 14, 2017. American Academy of Ophthalmology Instructional Course:  Diagnosis and Treatment of PCV.  Gregg T. Kokame, MD, MMM.  American Academy of OphthalmologyNew Orleans, Louisiana.

October 7, 2017. Prevalence of Polypoidal Choroidal Vasculopathy(PCV) in Wet Age-Related Macular Degeneration Eyes with and without Anti-VEGF Resistance and Diagnostic Imaging of PCV with En-face Optical Coherence Tomography(OCT) and OCT Angiography. Gregg T. Kokame, MD, MMM. 50th Anniversary of the Retina Society. Annual Meeting. Boston, Massachusetts. 

August 12, 2017. Long Term Stability of Suture-Fixated PCIOL – Up to 24 year. Gregg T. Kokame, MD, MMM. Pan-American Congress of Ophthalmology. Annual Meeting. Lima, Peru.

August 12, 2017. History of Macular Hole Surgery—From Idea to Modern Day.  Gregg T. Kokame, MD, MMM. Pan-American Congress of Ophthalmology. Annual Meeting. Lima, Peru.

August 11, 2017. New Diagnostic and Treatment Alternatives: Paradigm for PCV. Gregg T. Kokame, MD, MMM. Pan-American Congress of Ophthalmology. Annual Meeting. Lima, Peru.

March 7, 2017. Update on Eylea for AMD and Retinal Vascular Disease. Gregg T. Kokame, MD, MMM. Aspen Retinal Detachment Society. Annual Meeting. Snowmass, Colorado.

March 6, 2017. Polypoidal Choroidal Vasculopathy – A Variant of Type I CNV – Implications for Diagnosis and Management. Gregg T. Kokame, MD, MMM. Aspen Retinal Detachment Society Meeting. Annual Meeting.  Snowmass, Colorado.

December 2016. Treatment and Management of Polypoidal Choroidal Vasculopathy. Gregg T. Kokame, MD, MMM. 55th Annual Japanese Retina Vitreous Society. Tokyo, Japan.

October 14, 2016. Polypoidal Variants and Outcomes. Gregg T. Kokame, MD, MMM. American Academy of Ophthalmology. Annual Meeting. Chicago, Illinois.

August 11, 2016. High-Dose Ranibizumab Treatment in Polypoidal Choroidal Vasculopathy: PEARL2 Trial. Raymond Wee, MD. American Society of Retinal Specialists. Annual Meeting. San Francisco, California.

February 26, 2016. Multimodality Imaging for Polypoidal Choroidal Vasculopathy. Gregg T. Kokame, MD, MMM.  Macula Society. Annual Meeting. Miami, Florida.

January 19, 2016.  PDT for the Management of Polypoidal Choroidal Vasculopathy.    Gregg T. Kokame, MD, MMM.  Retina 2016Big Island, Hawaii.

November 17, 2015.  American Academy of Ophthalmology Instructional Course:  Diagnosis and Treatment of PCV.  Gregg T. Kokame, MD, MMM.  American Academy of OphthalmologyLas Vegas, Nevada.

November 15, 2015:  American Academy of Ophthalmology Advisory Board: PCV- A Worldwide Problem.  Gregg T. Kokame, MD, MMM.  American Academy of Ophthalmology.   Annual Meeting.  Las Nevas, Nevada.

August 2, 2015:  Epiretinal Prosthesis for Retinitis Pigmentosa.  Gregg T. Kokame, MD, MMM.  Macular Surgery Symposium.  Asia Pacific Vitreoretinal SocietySydney, Australia.

July 19, 2015:  En Face OCT Findings in Polypoidal Choroidal Vasculopathy.  Gregg T. Kokame, MD, MMM.  American Society of Retina Specialists.  Annual Meeting.  Vienna, Austria.

May 5, 2015:  Prospective evaluation of subretinal vessel location in PCV and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy. An American Ophthalmological Society Thesis. Gregg T Kokame MD, MMM. Annual Meeting. American Ophthalmological Society Meeting. Newport, Rhode Island.

April 27, 2015April 28, 2015:  Lectures on PCV and EPIC study throughout Korea. Gregg T. Kokame MD, MMM. Korea.

April 24, 2015-April 26, 2015: Lectures on PCV and EPIC study throughout Taiwan. Gregg T. Kokame MD, MMM. Taiwan.

February 28, 2015: Aflibercept for Hemorrhagic and Exudative Complication of PCV – Prospective 6 month Results of EPIC study. Gregg T. Kokame MD MMM, James C. Lai MD, Raymond Wee MD, Ryan Yanagihara BS. Macula Society. Annual Meeting.  Scottsdale, Arizona.

February 25, 2015: Polypoidal Choroidal Vaculopathy- Is It Choroidal?  Gregg T. Kokame, MD, MMM.  Macula Society.  Annual Meeting.  Scottsdale, Arizona.

January 19, 2015:  Insights on the role of PDT in retina practice.  Gregg T. Kokame, MD, MMM. Hawaiian Eye-Retina 2015Maui, HI.

December 21, 2014: En Face OCT Imaging of PCV. Gregg T. Kokame MD, MMM, Kelsi Hirai MSII, Julia Ayabe MSI. Second International Congress of “En Face OCT Imaging.Rome, Italy.

November 6, 2014: Comparison of Anti-VEGF Agents in the Treatment of Macular Edema from Retinal Vein Occlusion. Raymond Wee, MD. Study Club for Ophthalmological Research Hawaii.  Honolulu, HI.

October 21, 2014: Polypoidal Choroidal Vasculopathy (PCV). Gregg T. Kokame, MD, MMM. American Academy Course at American Academy of Ophthalmology Annual Meeting. Chicago, Illinois.

September 13, 2014: Antiangiogenic Therapy for PCV.  Gregg T. Kokame, MD, MMM.  Euretina Annual MeetingLondon, England.

September 12, 2014: The role of anti-VEGF in the treatment of PCV. Gregg T. Kokame, MD, MMM. Euretina Annual MeetingLondon, England.

September 6, 2014: Novel Treatments for Diabetic Macular Edema.  James Lai, MD.  Hawaiian Ophthalmological Society annual meetingHonolulu, HI.

September 6, 2014: A Few Bizarre Things: Case Presentations.  Raymond Wee, MD.  Hawaiian Ophthalmological Society annual meeting.  Honolulu, HI.

August 12, 2014.  Comparison of Monthly Treatment of 2.0 mg Ranibizumab for PCV.  Raymond Wee, MD.  American Society of Retina Specialists.  San Diego, CA.

August 12, 2014: Location of PCV Vessels by ICG-Correlated OCT and Response to High Dose Ranibizumab.  Gregg T. Kokame, MD, MMMAmerican Society of Retina SpecialistsSan Diego, CA.

May 6, 2014:  New Treatments for Vein Occlusions.  James Lai, MD.  Hawaiian Ophthalmological Society.  Honolulu, HI.

April 4, 2014: My Best Buckle Complication Surgical Management Video.  Gregg T. Kokame, MD, MMM.  World Ophthalmology Congress.  Tokyo, Japan.

April 3, 2014:  Polypoidal Choroidal Vasculopathy.  Gregg T. Kokame, MD, MMM.  World Ophthalmology Congress.  Tokyo, Japan.